TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Fundamental Analysis
USA - NASDAQ:TCMD - US87357P1003 - Common Stock
14.92 USD
-0.25 (-1.65%)
Taking everything into account, TCMD scores 6 out of 10 in our fundamental rating. TCMD was compared to 191 industry peers in the Health Care Equipment & Supplies industry. TCMD has an excellent financial health rating, but there are some minor concerns on its profitability. TCMD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
TCMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TCMD reported negative net income in multiple years.
TCMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.54%, TCMD belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
TCMD has a Return On Equity of 7.75%. This is amongst the best in the industry. TCMD outperforms 80.63% of its industry peers.
TCMD has a better Return On Invested Capital (5.85%) than 79.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.54% | ||
| ROE | 7.75% | ||
| ROIC | 5.85% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.06%, TCMD is in the better half of the industry, outperforming 76.96% of the companies in the same industry.
TCMD's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 6.30%, TCMD is in the better half of the industry, outperforming 72.25% of the companies in the same industry.
TCMD's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 49.70%, TCMD perfoms like the industry average, outperforming 43.98% of the companies in the same industry.
In the last couple of years the Gross Margin of TCMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.3% | ||
| PM (TTM) | 5.06% | ||
| GM | 49.7% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TCMD is destroying value.
The number of shares outstanding for TCMD has been increased compared to 1 year ago.
Compared to 5 years ago, TCMD has more shares outstanding
TCMD has a better debt/assets ratio than last year.
2.2 Solvency
TCMD has an Altman-Z score of 4.60. This indicates that TCMD is financially healthy and has little risk of bankruptcy at the moment.
TCMD's Altman-Z score of 4.60 is fine compared to the rest of the industry. TCMD outperforms 76.96% of its industry peers.
The Debt to FCF ratio of TCMD is 0.63, which is an excellent value as it means it would take TCMD, only 0.63 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.63, TCMD belongs to the best of the industry, outperforming 92.15% of the companies in the same industry.
TCMD has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
TCMD has a Debt to Equity ratio of 0.11. This is in the better half of the industry: TCMD outperforms 63.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 4.6 |
ROIC/WACC0.69
WACC8.52%
2.3 Liquidity
A Current Ratio of 3.79 indicates that TCMD has no problem at all paying its short term obligations.
TCMD's Current ratio of 3.79 is fine compared to the rest of the industry. TCMD outperforms 67.54% of its industry peers.
A Quick Ratio of 3.36 indicates that TCMD has no problem at all paying its short term obligations.
TCMD has a better Quick ratio (3.36) than 70.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.36 |
3. Growth
3.1 Past
TCMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.40%.
The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
The Revenue has been growing slightly by 6.15% in the past year.
TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.11% yearly.
EPS 1Y (TTM)-55.4%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)6.15%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%7.77%
3.2 Future
Based on estimates for the next years, TCMD will show a very strong growth in Earnings Per Share. The EPS will grow by 30.86% on average per year.
The Revenue is expected to grow by 8.78% on average over the next years. This is quite good.
EPS Next Y-10.57%
EPS Next 2Y12.44%
EPS Next 3Y30.86%
EPS Next 5YN/A
Revenue Next Year6.71%
Revenue Next 2Y7.6%
Revenue Next 3Y8.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.06, TCMD is valued on the expensive side.
Based on the Price/Earnings ratio, TCMD is valued a bit cheaper than 77.49% of the companies in the same industry.
TCMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.62, the valuation of TCMD can be described as correct.
TCMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. TCMD is cheaper than 82.20% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, TCMD is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.06 | ||
| Fwd PE | 16.62 |
4.2 Price Multiples
TCMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TCMD is cheaper than 91.62% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TCMD is valued cheaper than 97.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.42 | ||
| EV/EBITDA | 9.83 |
4.3 Compensation for Growth
The decent profitability rating of TCMD may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 30.86% in the coming years.
PEG (NY)N/A
PEG (5Y)4.95
EPS Next 2Y12.44%
EPS Next 3Y30.86%
5. Dividend
5.1 Amount
No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:TCMD (10/7/2025, 11:45:01 AM)
14.92
-0.25 (-1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.61%
Inst Owner Change0%
Ins Owners2.67%
Ins Owner Change5.82%
Market Cap332.57M
Analysts78
Price Target13.77 (-7.71%)
Short Float %9.55%
Short Ratio9.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.49%
Min EPS beat(2)-82.07%
Max EPS beat(2)27.09%
EPS beat(4)3
Avg EPS beat(4)-3.56%
Min EPS beat(4)-82.07%
Max EPS beat(4)27.09%
EPS beat(8)7
Avg EPS beat(8)416.91%
EPS beat(12)10
Avg EPS beat(12)294.05%
EPS beat(16)10
Avg EPS beat(16)151.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-5.08%
Max Revenue beat(2)4.63%
Revenue beat(4)1
Avg Revenue beat(4)-1.98%
Min Revenue beat(4)-5.72%
Max Revenue beat(4)4.63%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)6
Avg Revenue beat(12)0.56%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)0%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.57%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)11.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.06 | ||
| Fwd PE | 16.62 | ||
| P/S | 1.11 | ||
| P/FCF | 8.42 | ||
| P/OCF | 7.96 | ||
| P/B | 1.71 | ||
| P/tB | 2.7 | ||
| EV/EBITDA | 9.83 |
EPS(TTM)0.62
EY4.16%
EPS(NY)0.9
Fwd EY6.02%
FCF(TTM)1.77
FCFY11.87%
OCF(TTM)1.87
OCFY12.56%
SpS13.41
BVpS8.74
TBVpS5.52
PEG (NY)N/A
PEG (5Y)4.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.54% | ||
| ROE | 7.75% | ||
| ROCE | 8.1% | ||
| ROIC | 5.85% | ||
| ROICexc | 9.95% | ||
| ROICexgc | 21.02% | ||
| OM | 6.3% | ||
| PM (TTM) | 5.06% | ||
| GM | 49.7% | ||
| FCFM | 13.21% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.85 | ||
| Cap/Depr | 33.28% | ||
| Cap/Sales | 0.76% | ||
| Interest Coverage | 10.27 | ||
| Cash Conversion | 162.7% | ||
| Profit Quality | 261.27% | ||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.36 | ||
| Altman-Z | 4.6 |
F-Score6
WACC8.52%
ROIC/WACC0.69
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.4%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%-22.22%
EPS Next Y-10.57%
EPS Next 2Y12.44%
EPS Next 3Y30.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.15%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%7.77%
Revenue Next Year6.71%
Revenue Next 2Y7.6%
Revenue Next 3Y8.78%
Revenue Next 5YN/A
EBIT growth 1Y-16.93%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year62.97%
EBIT Next 3Y45.27%
EBIT Next 5YN/A
FCF growth 1Y133.94%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y113.95%
OCF growth 3Y149.11%
OCF growth 5Y74.54%